High Fecal Viral Levels Found in COVID-19 Disease and in Asymptomatic Carriers
Data from 98 COVID-19 patients showed viral shedding in stool for nearly five weeks after respiratory samples were negative to optimize Gut Health to Reduce the Impact of Coronavirus Infection.
Given the role of SARS-CoV-2 in gastrointestinal infection, GI symptoms, and disease severity, a healthy GI tract could reduce infection and/or severity of COVID-19.
By optimizing gut health, we may be able to protect patients from further complications caused by SARS-CoV-2.
Cutting-edge viral RNA qPCR stool test measures levels of SARS-CoV-2, the virus that causes COVID-19.
Screen, monitor, or prevent transmission in patients at risk for COVID-19.
SARS-CoV-2 in stool may be found in up to 53.4% of COVID-19 patients.
The virus may be detected in stool for a period of days to weeks after initial infection.
Intestinal viral infection may play an important role in COVID-19 disease progression and may increase risk for more severe disease.
Detection of SARS-CoV-2 in stool could be used to prevent faecal-oral transmission